In summary, we identified a novel de novo PRKAG2 mutation (K485E) in a young patient with ventricular preexcitation, conduction defect, cardiac hypertrophy and rapid progression of heart failure. This evidence concerns the gene PRKAG2 and cardiac hypertrophy.